Persistent URL of this record https://hdl.handle.net/1887/106796
In Collections
This item can be found in the following collections:
Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013)
- All authors
- Witte, T. de; Suciu, S.; Meert, L.; Halkes, C.; Selleslag, D.; Bron, D.; Amadori, S.; Willemze, R.; Muus, P.; Baron, F.
- Date
- 2015-12-31
- Journal
- Annals of Hematology
- Volume
- 94
- Issue
- 12
- Pages
- 1981 - 1989